LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Neuroscience Research to Benefit from 3-D Printing of Brain-Like Structures

By LabMedica International staff writers
Posted on 12 Aug 2015
Print article
Image: The Connex Objet350 3-D printer represents the current state of the art in polymer rapid prototyping systems (Photo courtesy of Stratasys Ltd.).
Image: The Connex Objet350 3-D printer represents the current state of the art in polymer rapid prototyping systems (Photo courtesy of Stratasys Ltd.).
Advanced three-dimensional printing techniques were used to generate a biological construct that incorporated neural cells and mimicked brain cell activities for use in applications ranging from cell behavior studies to improving understanding of brain injuries and neurodegenerative diseases.

Researchers have attempted to study the brain by modeling the architecture using two dimensional (2-D) in vitro cell culturing methods. While those platforms attempt to mimic the in vivo environment, they do not truly resemble the three dimensional (3-D) microstructure of neuronal tissues. Development of an accurate in vitro model of the brain remains a significant obstacle to understanding the functioning of the brain at the tissue or organ level.

Investigators at the ARC Centre of Excellence for Electromaterials Science (North Wollongong, NSW, Australia) applied a 3-D printing approach to the problem of developing a useful in vitro brain model. They reported in the July 14, 2015, online edition of the journal Biomaterials that they had developed a new method to bioprint 3-D brain-like structures consisting of discrete layers of primary neural cells encapsulated in hydrogels.

Brain-like structures were constructed with a Stratasys Ltd. (Rehovot, Israel) Connex Objet350 3D printer using a bio-ink consisting of a novel peptide-modified biopolymer, gellan gum-RGD (RGD-GG), combined with primary cortical neurons. The ink was optimized for a modified reactive printing process and developed for use in traditional cell culturing facilities without the need for extensive bioprinting equipment. Furthermore, the peptide modification of the gellan gum hydrogel was found to have a profound positive effect on primary cell proliferation and network formation. Neural cell viability combined with the support of neural network formation demonstrated the cell supportive nature of the matrix.

"This study highlights the importance of integrating advances in 3-D printing, with those in materials science, to realize a biological outcome," said senior author Dr. Gordon Wallace, head of the ARC Centre of Excellence for Electromaterials Science.

"This paves the way for the use of more sophisticated printers to create structures with much finer resolution. We are still a long way from printing a brain but the ability to arrange cells so as they form neuronal networks is a significant step forward."

Related Links:

ARC Centre of Excellence for Electromaterials Science
Stratasys Ltd.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more